Primary literature evidence
Search paper-level observations with their value, target, assay, evidence sentence, source location, and stable record links. Evidence without a safely standardized sequence remains visible without being misrepresented as a canonical peptide.
Evidence records
Table 5: SL identified in MCC D, MBP D, SPC D. Section 2.4 and Table 6 indicate DPP-IV inhibitory activity. No IC50 value in provided text.
Table 1: ADR5-4, Ser-Leu, IC50 >200 μM
Table 6: SL docking score -85.505 against DPP-IV.
Names such as P1, PEP1, or peptide 1 are paper-local labels. Search results group them by publication and never assume cross-paper molecular identity without sequence or explicit structural evidence.
